Profile data is unavailable for this security.
About the company
Menicon Co., Ltd. is a Japan-based company mainly engaged in operation of contact lens related business and other business. The Company has two business segments. With its subsidiaries, the Contact Lens segment is engaged in manufacture and sales of contact lens, care supplies and other goods. The Others segment is engaged in development and sales of veterinary medical products, decomposition accelerator of rice straw, composting accelerator of livestock excrement, assisted reproductive medicine and products of advanced medical fields, as well as management of contact lens retailer staff training school and provision of temporary staffing service, among others.
- Revenue in JPY (TTM)116.19bn
- Net income in JPY4.54bn
- Incorporated1957
- Employees4.06k
- LocationMenicon Co Ltd3-21-19, Aoi, Naka-kuNAGOYA-SHI 460-0006JapanJPN
- Phone+81 529351515
- Websitehttps://www.menicon.co.jp/
More ▼
Mergers & acquisitions
| Acquired company | 7780:TYO since announced | Transaction value |
|---|---|---|
| Dencott Laboratories SA | -9.05% | -- |
Data delayed at least 20 minutes, as of May 17 2024 07:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Sanyou Medical Co Ltd | 8.32bn | 1.27bn | 96.58bn | 466.00 | 79.11 | 2.34 | -- | 11.61 | 0.228 | 0.228 | 1.53 | 7.71 | 0.1699 | 0.5891 | 2.20 | 828,288.80 | 3.29 | 9.42 | 3.86 | 10.85 | 71.52 | 87.15 | 19.34 | 29.78 | 3.35 | -- | 0.0291 | 16.21 | -29.08 | 15.67 | -49.91 | 8.99 | -15.60 | -- |
| Shanghai INT Medical Instruments Co Ltd | 16.23bn | 3.37bn | 97.27bn | 1.57k | 28.10 | 2.64 | 22.47 | 5.99 | 0.9858 | 0.9858 | 4.74 | 10.48 | 0.3904 | 2.22 | 7.75 | 519,242.10 | 7.95 | 8.63 | 9.49 | 9.76 | 58.19 | 59.44 | 20.35 | 26.16 | 1.88 | -- | 0.0535 | 31.80 | 28.50 | 29.96 | 18.79 | 21.76 | 45.75 | -- |
| Hangzhou Ags Medtech Co Ltd | 11.42bn | 5.08bn | 99.08bn | 592.00 | 19.50 | 2.04 | -- | 8.68 | 4.07 | 4.07 | 9.16 | 38.92 | 0.3775 | 3.36 | 13.43 | 895,039.90 | 16.80 | -- | 17.73 | -- | 70.24 | -- | 44.50 | -- | 24.45 | -- | 0.0054 | -- | 37.09 | -- | 49.87 | -- | -- | -- |
| HOGY MEDICAL CO., LTD. | 39.10bn | 2.80bn | 99.51bn | 1.44k | 34.10 | 1.11 | 10.59 | 2.55 | 115.55 | 115.55 | 1,611.17 | 3,547.48 | 0.3867 | 2.84 | 4.99 | -- | 2.76 | 4.24 | 3.06 | 4.67 | 33.41 | 39.76 | 7.14 | 11.58 | 4.07 | -- | 0.0618 | 42.57 | 0.3053 | 1.30 | -35.03 | -14.24 | 7.94 | 4.56 |
| Modern Dental Group Ltd | 63.29bn | 8.06bn | 99.53bn | 7.04k | 12.39 | 1.90 | 9.11 | 1.57 | 0.4245 | 0.4245 | 3.33 | 2.78 | 0.8468 | 9.10 | 5.49 | 450,895.30 | 10.74 | 7.05 | 12.60 | 8.34 | 53.61 | 50.77 | 12.68 | 9.24 | 2.53 | 13.17 | 0.2438 | 39.98 | 12.08 | 6.50 | 83.30 | 36.46 | 2.42 | -- |
| Menicon Co Ltd | 116.19bn | 4.54bn | 106.25bn | 4.06k | 25.18 | 1.29 | 10.20 | 0.9145 | 55.06 | 55.06 | 1,433.51 | 1,072.69 | 0.6993 | 3.05 | 9.13 | -- | 2.73 | 4.53 | 3.52 | 5.67 | 52.51 | 52.97 | 3.91 | 5.72 | 1.34 | 13.77 | 0.4639 | 26.44 | 5.44 | 7.51 | -38.48 | 4.88 | 32.61 | 12.30 |
| SWS Hemodialysis Care Co Ltd | 14.20bn | 3.32bn | 108.08bn | 881.00 | 32.54 | 2.92 | -- | 7.61 | 0.7148 | 0.7148 | 3.06 | 7.97 | 0.3351 | 2.11 | 5.56 | 748,197.70 | 7.71 | -- | 8.68 | -- | 50.81 | -- | 23.00 | -- | 15.96 | -- | 0.0089 | -- | 80.65 | -- | 228.34 | -- | -- | -- |
| Hubei Huaqiang High-Tech Co Ltd | 10.82bn | 106.62m | 109.05bn | 706.00 | 1,022.27 | 1.21 | -- | 10.08 | 0.0144 | 0.0144 | 1.46 | 12.15 | 0.0993 | 1.83 | 0.7415 | 711,388.30 | 0.0978 | 3.82 | 0.1078 | 4.62 | 11.73 | 26.28 | 0.9853 | 14.29 | 7.84 | -- | 0.0043 | 20.55 | -2.21 | -5.08 | -88.36 | -40.15 | -12.17 | -- |
| Sino Medical Sciences Technology Inc | 7.78bn | -450.83m | 109.28bn | 652.00 | -- | 6.17 | -- | 14.04 | -0.051 | -0.051 | 0.8809 | 2.00 | 0.3109 | 1.34 | 24.46 | 553,914.40 | -1.62 | -4.21 | -1.95 | -4.71 | 58.14 | 70.96 | -5.22 | -15.76 | 1.55 | -- | 0.1442 | -- | 77.99 | -2.04 | 75.59 | -- | -7.30 | -- |
| Zhejiang Gongdong Medical Techno Co Ltd | 22.00bn | 2.70bn | 117.28bn | 1.67k | 43.38 | 3.23 | -- | 5.33 | 1.11 | 1.11 | 9.07 | 14.98 | 0.5447 | 6.00 | 4.59 | 609,805.40 | 6.69 | 16.35 | 7.46 | 19.26 | 31.13 | 41.19 | 12.28 | 21.62 | 3.85 | -- | 0.0201 | 38.99 | -33.61 | 15.11 | -66.53 | 5.14 | 27.71 | -- |
Data as of May 17 2024. Currency figures normalised to Menicon Co Ltd's reporting currency: Japanese Yen JPY
19.94%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Global Alpha Capital Management Ltd.as of 16 Feb 2024 | 3.75m | 4.89% |
| Nomura Asset Management Co., Ltd.as of 30 Dec 2022 | 2.91m | 3.79% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 1.75m | 2.28% |
| Asset Management One Co., Ltd.as of 15 Nov 2023 | 1.45m | 1.89% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 1.05m | 1.38% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 988.30k | 1.29% |
| Nikko Asset Management Co., Ltd.as of 05 Apr 2024 | 984.10k | 1.28% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 961.30k | 1.26% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 761.20k | 0.99% |
| Silvercross Investment Management BVas of 31 Aug 2023 | 681.47k | 0.89% |
More ▼
Data from 31 Aug 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
